Abbott Laboratories (NYSE:ABT) Issues FY 2025 Earnings Guidance
Abbott Laboratories (NYSE:ABT – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 5.050-5.250 for the period, compared to the consensus EPS estimate of 5.160. The company issued revenue guidance of -. Abbott Laboratories also updated its Q1 2025 guidance to 1.050-1.090 EPS. […]
More Stories
Who is Allie Rebelo? And Her Relationship With Justin and Hailey Bieber
Have you also seen Allie Rebelo video on TikTok? And now wants to know about who is Allie Bieber and...
Trump Tells Germany’s Merz to Stop Interfering Over Iran
By Victoria Friedman U.S. President Donald Trump has again criticized German Chancellor Friedrich Merz over Iran, telling Merz to stop...
Trump Signs Order Targeting ‘Bloated Overhead’ in Federal Contracts
By Tom Gantert President Donald Trump signed an executive order Thursday that seeks to address longstanding problems in the federal...
Trump Signs DHS Funding Bill, Ending Shutdown
By Jackson Richman and Joseph Lord President Donald Trump on April 30 signed legislation ending the Department of Homeland Security...
US Economy Rebounds With 2 Percent Growth in 1st Quarter
By Andrew Moran The U.S. economy registered a solid rebound in the first quarter after a disappointing end to 2025,...
Louisiana Governor Signals House Primaries Will Be Postponed After Supreme Court Redistricting Ruling
By Jacki Thrapp Louisiana plans to postpone U.S. House primaries in order to allow time for lawmakers to redraw and...